Research Institute of Internal and Preventive Medicine – Branch of Federal Research Center Institute of Cytology and Genetics of SB RAS Russian Federation
E. V. Kashtanova
Research Institute of Internal and Preventive Medicine – Branch of Federal Research Center Institute of Cytology and Genetics of SB RAS Russian Federation
E. M. Stakhneva
Research Institute of Internal and Preventive Medicine – Branch of Federal Research Center Institute of Cytology and Genetics of SB RAS Russian Federation
E. V. Sadowski
Research Institute of Internal and Preventive Medicine – Branch of Federal Research Center Institute of Cytology and Genetics of SB RAS Russian Federation
Yu. I. Ragino
Research Institute of Internal and Preventive Medicine – Branch of Federal Research Center Institute of Cytology and Genetics of SB RAS Russian Federation
At the beginning of June 2020, more than 7 million people were identified worldwide with COVID-19, a new coronavirus infection that has spread around the world, more than 400 thousand people have died. In Russia, the number of cases exceeded 470 000 people, and more than 5900 died [https://covid19-2020.info/]. More and more researchers report a greater likelihood of infection and adverse disease course in people with cardiovascular diseases, which makes it necessary to study the effect of SARS-CoV-2 on the cardiovascular system. This article provides an analysis of the publications for the year 2020 from the databases of PubMed, Google Scholar, and E-library on this issue.
